
Loading, please wait...

Loading, please wait...

India currently faces a massive gap in healthcare where less than 1% of patients receive essential end-of-life support. Consequently, the Indian Council of Medical Research (ICMR) is initiating a landmark multi-state study to expand palliative care access India. This implementation research targets the public health system to provide relief for those with serious chronic illnesses. Furthermore, the program focuses on conditions like cancer, advanced neurological disorders, and chronic respiratory diseases. However, current statistics show that 6.21 per 1,000 people in India require these services immediately. Therefore, the ICMR study will evaluate models across district hospitals and primary health centers to bridge this divide.
The demand for specialized end-of-life care is rising sharply due to an aging population and non-communicable diseases. Additionally, the World Health Organization predicts an 87% increase in serious health-related suffering by 2060. Specifically, rural areas and elderly populations face the highest burden of unaddressed pain. Because of limited trained personnel and regulatory barriers, most families suffer significant financial and emotional strain. Moreover, the lack of home-based options often leads to high out-of-pocket expenses. This ICMR initiative aims to test scalable models that integrate palliative care into routine medical services. Finally, successful integration could lower hospitalization rates and improve the quality of life for millions of Indian citizens.
Q1: Why is palliative care access India currently so limited?
Access remains low due to a shortage of trained healthcare workers, limited services at the grassroots level, and regulatory hurdles regarding pain management medications.
Q2: What is the primary objective of the ICMR multi-state study?
The study aims to develop and test scalable palliative care models within the existing public health infrastructure, including community health centers and home-based settings.
Q3: How will the study benefit families of patients with chronic illnesses?
By integrating palliative care into routine services, the study hopes to reduce the caregiver burden and lower the high out-of-pocket costs associated with long-term care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


ICMR launches a multi-state study to expand palliative care access in India, targeting public health systems to reduce suffering and lower healthcare costs....
6 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday